Issue Permissible and Mandatory Labeling

According to the Task Force, because current science does not support a finding that classes of products with nanoscale materials necessarily present greater safety concerns than classes of products without nanoscale materials, the Task Force does not believe there is a basis for saying that, as a general matter, a product containing nanoscale materials must be labeled as such Therefore the Task Force does not recommend that the FDA require such labeling at this time Instead, the Task Force recommends that the FDA address on a case-by-case basis whether labeling must or may contain information on the use of nanoscale materials

Was this article helpful?

0 0

Post a comment